Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Biobankhealing Inc. is currently managing 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This matter is assigned to 1 distinct examiner, HAMA, JOANNE. The company's active prosecution is limited to 1 distinct art unit. This organizational structure suggests a highly focused prosecution strategy in this specific technological field, as the company is not currently navigating multiple art units or examiner perspectives.
HAMA, JOANNE is the busiest examiner for the company, overseeing 1 pending office action. This single action accounts for the company's entire pending workload. The concentration of 1 pending office action under 1 distinct examiner in 1 distinct art unit reflects a specific and narrow focus within the biotechnology sector. For a practitioner, this means that the company's current success in the Biotechnology & Pharmaceuticals sector depends on the outcomes of this singular interaction, emphasizing the importance of this specific examiner relationship.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HAMA, JOANNE | 1 | 25.4% | +40.2% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18294819 | BLAUTIA SP. STRAIN, LEUCONOSTOC SP. STRAIN, OR RUMINOCOCCUS SP. STRAIN AND ENDOPLASMIC RETICULUM DERIVED THEREFROM, AND ANTI-INFLAMMATORY AND ANTIBACTERIAL USES THEREOF | HAMA, JOANNE | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18294819 | BLAUTIA SP. STRAIN, LEUCONOSTOC SP. STRAIN, OR RUMINOCOCCUS SP. STRAIN AND ENDOPLASMIC RETICULUM DERIVED THEREFROM, AND ANTI-INFLAMMATORY AND ANTIBACTERIAL USES THEREOF | HAMA, JOANNE | — |
| Art Unit | Apps |
|---|---|
| 1645 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18294819 | BLAUTIA SP. STRAIN, LEUCONOSTOC SP. STRAIN, OR RUMINOCOCCUS SP. STRAIN AND ENDOPLASMIC RETICULUM DERIVED THEREFROM, AND ANTI-INFLAMMATORY AND ANTIBACTERIAL USES THEREOF | HAMA, JOANNE | 1645 | §102§103§112 | Non-Final OA | — | Pending | Apr 01, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialBiobankhealing Inc. has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Joanne Hama has the most, with 1 of Biobankhealing Inc.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
